Meridian Bioscience, Inc. (VIVO) - Financial and Strategic SWOT Analysis Review

Document Sample
Meridian Bioscience, Inc. (VIVO) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					                Meridian Bioscience, Inc. (VIVO) - Financial and Strategic SWOT
                                       Analysis Review
        Reference Code: GDME238FSA                                                                                             Publication Date: JAN 2013

          3471 River Hills Drive                          Phone             +1 513 2713700                          Revenue         173.5 (million USD)
          Cincinnati, OH                                  Fax               +1 513 2713762                          Net Profit      33.37 (million USD)
          45244                                           Website           www.meridianbioscience.com              Employees       510
          United States                                   Exchange          VIVO [NASDAQ]                           Industry        Medical Equipment

       Company Overview
       Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company. It undertakes the research, development,
       manufacture and distribution of a wide range of diagnostic test kits, purified reagents and related products. The company also
       offers biopharmaceutical enabling technologies and a variety of biological and non-biological materials for use in proficiency
       testing programs. Meridian's strong therapeutic areas are gastrointestinal and upper respiratory infections, serology, parasitology
       and fungal disease diagnosis.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Meridian Bioscience, Inc., SWOT Analysis
         William J. Motto                    Chairman                                 Strengths                            Weaknesses
         John A. Kraeutler                   Chief Executive Officer
                                                                                      Broad Product Portfolio              Reliance on Key Distributors
         Robert J. Ready                     Director
                                                                                      Strong Research and                  Over Dependence on a Single
         David C. Phillips                   Director
                                                                                      Development Activities               Segment
         James M. Anderson                   Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                        Threats

       Share Data                                                                     Regulatory Approvals                 Intense Competition
         Meridian Bioscience, Inc.
                                                                                      Growing IVD Market                   Government Regulations
        Share Price (USD) as on 09-Jan-                                20.97
        2013
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (USD)                                                        0.80        GlobalData
        Market Cap (million USD)                                         866
        Enterprise Value (million USD)                                   835
        Shares Outstanding (million)                                       41
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Dec 13, 2012         Meridian Bioscience Successfully Completes
                                                                                                           Beta Trials For Two New illumigene Tests
                                                                                      Nov 08, 2012         Meridian Bioscience Reports Revenue Of
                                                                                                           $173.5m In Fiscal 2012
                                                                                      Jul 26, 2012         Meridian Bioscience Reports Revenue Of
                                                                                                           $42.1m In Q3 Fiscal 2012
                                                                                      Apr 26, 2012         Meridian Bioscience Reports Revenue Of
                                                                                                           $47.4m In Q2 Fiscal 2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Meridian Bioscience, Inc. (VIVO) - Financial and Strategic SWOT                                                                  Reference Code: GDME238FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Meridian Bioscience, Inc. - Key Facts ................................................................................................................................................ 5
       Meridian Bioscience, Inc. - Key Employees........................................................................................................................................ 6
       Meridian Bioscience, Inc. - Key Employee Biographies ..................................................................................................................... 7
       Meridian Bioscience, Inc. - Major Products and Services ................................................................................................................... 8
       Meridian Bioscience, Inc. - Medical Equipment Pipeline Products Data........................................................................................... 12
          Meridian Bioscience, Inc. Pipeline Products by Equipment Type ................................................................................................. 12
          Meridian Bioscience, Inc. Pipeline Products by Development Stage ............................................................................................ 14
       Meridian Bioscience, Inc. - History ................................................................................................................................................... 16
       Meridian Bioscience, Inc. - Company Statement .............................................................................................................................. 19
       Meridian Bioscience, Inc. - Locations And Subsidiaries ................................................................................................................... 21
          Head Office ................................................................................................................................................................................... 21
          Other Locations & Subsidiaries ..................................................................................................................................................... 21
       Meridian Bioscience, Inc. - Key Manufacturing Facilities .................................................................................................................. 23
       Section 2 – Company Analysis ......................................................................................................................................................... 24
       Meridian Bioscience, Inc. - Business Description ............................................................................................................................. 24
       Meridian Bioscience, Inc. - Corporate Strategy ................................................................................................................................ 25
       Meridian Bioscience, Inc. - SWOT Analysis ..................................................................................................................................... 26
          SWOT Analysis - Overview........................................................................................................................................................... 26
          Meridian Bioscience, Inc. - Strengths............................................................................................................................................ 26
             Strength - Broad Product Portfolio ............................................................................................................................................ 26
             Strength - Strong Research and Development Activities........................................................................................................... 26
             Strength - Strategic Acquisitions ............................................................................................................................................... 26
             Strength - Increased Profitability Ratios .................................................................................................................................... 27
          Meridian Bioscience, Inc. - Weaknesses ...................................................................................................................................... 27
             Weakness - Reliance on Key Distributors ................................................................................................................................. 27
             Weakness - Over Dependence on a Single Segment ............................................................................................................... 27
          Meridian Bioscience, Inc. - Opportunities...................................................................................................................................... 27
             Opportunity - Regulatory Approvals .......................................................................................................................................... 27
             Opportunity - Growing IVD Market ............................................................................................................................................ 28
             Opportunity - Growing Market for Infectious Disease Tests ...................................................................................................... 28
          Meridian Bioscience, Inc. - Threats ............................................................................................................................................... 28
             Threat - Intense Competition ..................................................................................................................................................... 28
             Threat - Government Regulations ............................................................................................................................................. 28
             Threat - Cost Containment Pressures ....................................................................................................................................... 29
             Threat - Changing Diagnostic Market Conditions ...................................................................................................................... 29
       Meridian Bioscience, Inc. - Key Competitors .................................................................................................................................... 30
       Section 3 – Company Financial Ratios ............................................................................................................................................. 31
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 31
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 31
       Performance Chart ........................................................................................................................................................................... 33
       Financial Performance...................................................................................................................................................................... 33


Meridian Bioscience, Inc. (VIVO) - Financial and Strategic SWOT                                                                                                   Reference Code: GDME238FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in 
				
DOCUMENT INFO
Description: Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company. It undertakes the research, development, manufacture and distribution of a wide range of diagnostic test kits, purified reagents and related products. The company also offers biopharmaceutical enabling technologies and a variety of biological and non-biological materials for use in proficiency testing programs. Meridian's strong therapeutic areas are gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.